380 related articles for article (PubMed ID: 29181879)
1. High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality.
Winestone LE; Punn R; Tamaresis JS; Buckingham J; Pinsky BA; Waggoner JJ; Kharbanda S
Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29181879
[TBL] [Abstract][Full Text] [Related]
2. Human herpesvirus-6 viremia is not associated with poor clinical outcomes in children following allogeneic hematopoietic cell transplantation.
Violago L; Jin Z; Bhatia M; Rustia E; Kung AL; Foca MD; George D; Garvin JH; Sosna J; Robinson C; Karamehmet E; Satwani P
Pediatr Transplant; 2015 Nov; 19(7):737-44. PubMed ID: 26329541
[TBL] [Abstract][Full Text] [Related]
3. Long-term prognosis of human herpesvirus 6 reactivation following allogeneic hematopoietic stem cell transplantation.
Iesato K; Hori T; Yoto Y; Yamamoto M; Inazawa N; Kamo K; Ikeda H; Iyama S; Hatakeyama N; Iguchi A; Sugita J; Kobayashi R; Suzuki N; Tsutsumi H
Pediatr Int; 2018 Jun; 60(6):547-552. PubMed ID: 29542206
[TBL] [Abstract][Full Text] [Related]
4. Human Herpes Virus-6 Following Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
Shachor-Meyouhas Y; Fesenko A; Kra-Oz Z; Zaidman I; Szwarcwort-Cohen M; Shafran E; Kassis I
Isr Med Assoc J; 2015 May; 17(5):302-5. PubMed ID: 26137657
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of Human Herpes Virus-6 After Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association With Severity of Acute Graft-Versus-Host Disease.
Verhoeven DH; Claas EC; Jol-van der Zijde CM; Thijssen JC; Lankester AC; Bredius RG; Putter H; Kroes AC; Egeler RM; Schilham MW; van Tol MJ
Pediatr Infect Dis J; 2015 Oct; 34(10):1118-27. PubMed ID: 26132825
[TBL] [Abstract][Full Text] [Related]
6. Human herpesvirus-6B infection in pediatric allogenic hematopoietic stem cell transplant patients: Risk factors and encephalitis.
Miura H; Kawamura Y; Hattori F; Tanaka M; Kudo K; Ihira M; Yatsuya H; Takahashi Y; Kojima S; Sakaguchi H; Yoshida N; Hama A; Yoshikawa T
Transpl Infect Dis; 2020 Feb; 22(1):e13203. PubMed ID: 31650671
[TBL] [Abstract][Full Text] [Related]
7. Human herpesvirus-6 encephalitis during hematopoietic stem cell transplantation leads to poor prognosis.
Shimazu Y; Kondo T; Ishikawa T; Yamashita K; Takaori-Kondo A
Transpl Infect Dis; 2013 Apr; 15(2):195-201. PubMed ID: 23331378
[TBL] [Abstract][Full Text] [Related]
8. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H
Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the shedding of three β-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up.
Dzieciatkowski T; Tomaszewska A; Przybylski M; Rusicka P; Basak GW; Jedrzejczak WW; Wroblewska M; Halaburda K
J Clin Virol; 2016 Mar; 76():30-5. PubMed ID: 26809130
[TBL] [Abstract][Full Text] [Related]
10. Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.
Olson AL; Dahi PB; Zheng J; Devlin SM; Lubin M; Gonzales AM; Giralt SA; Perales MA; Papadopoulos EB; Ponce DM; Young JW; Kernan NA; Scaradavou A; O'Reilly RJ; Small TN; Papanicolaou G; Barker JN
Biol Blood Marrow Transplant; 2014 Jun; 20(6):787-93. PubMed ID: 24548875
[TBL] [Abstract][Full Text] [Related]
11. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
[TBL] [Abstract][Full Text] [Related]
12. HHV-6 encephalitis may complicate the early phase after allogeneic hematopoietic stem cell transplantation: Detection by qualitative multiplex PCR and subsequent quantitative real-time PCR.
Inazawa N; Hori T; Yamamoto M; Hatakeyama N; Yoto Y; Nojima M; Yasui H; Suzuki N; Shimizu N; Tsutsumi H
J Med Virol; 2016 Feb; 88(2):319-23. PubMed ID: 26241219
[TBL] [Abstract][Full Text] [Related]
13. Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation.
Miyashita N; Endo T; Onozawa M; Hashimoto D; Kondo T; Fujimoto K; Kahata K; Sugita J; Goto H; Matsukawa T; Hashino S; Teshima T
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207973
[TBL] [Abstract][Full Text] [Related]
14. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
Wang LR; Dong LJ; Zhang MJ; Lu DP
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
[TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus-6 and -7 in pediatric stem cell transplantation.
Savolainen H; Lautenschlager I; Piiparinen H; Saarinen-Pihkala U; Hovi L; Vettenranta K
Pediatr Blood Cancer; 2005 Nov; 45(6):820-5. PubMed ID: 15700258
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation.
Zerr DM; Corey L; Kim HW; Huang ML; Nguy L; Boeckh M
Clin Infect Dis; 2005 Apr; 40(7):932-40. PubMed ID: 15824982
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
18. Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT.
Hill JA; Nichols WG; Marty FM; Papanicolaou GA; Brundage TM; Lanier R; Zerr DM; Boeckh MJ
Blood; 2020 Apr; 135(17):1447-1451. PubMed ID: 32076716
[TBL] [Abstract][Full Text] [Related]
19. High Incidence of Early Human Herpesvirus-6 Infection in Children Undergoing Haploidentical Manipulated Stem Cell Transplantation for Hematologic Malignancies.
Perruccio K; Sisinni L; Perez-Martinez A; Valentin J; Capolsini I; Massei MS; Caniglia M; Cesaro S
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2549-2557. PubMed ID: 30067953
[TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation.
Jeulin H; Agrinier N; Guery M; Salmon A; Clément L; Bordigoni P; Venard V
Transplantation; 2013 May; 95(10):1292-8. PubMed ID: 23514960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
